Weight Loss Injections and Your Gallbladder: Safety, Risks and What to Watch For

You've started a weight loss injection and your upper abdomen is aching, here's what that might mean

Picture this: a few weeks into treatment, you notice a dull ache beneath your right ribcage after a meal. You search online, find a flood of alarming forum posts, and wonder whether your medicine has caused gallstones. The short answer is that gallbladder symptoms during GLP-1 treatment are possible and worth taking seriously, but abdominal discomfort during the early weeks is also very common for reasons that have nothing to do with the gallbladder, nausea, slowed gastric emptying and reflux are all typical as your system adjusts.

The mechanism behind the genuine gallbladder risk is well understood. When you lose weight at a meaningful pace, the liver releases extra cholesterol into bile, which can crystallise into stones. GLP-1 receptor agonists compound this slightly because they reduce how often the gallbladder squeezes and empties, and a gallbladder that doesn't empty fully is one that's more likely to develop sludge or stones over time. This isn't unique to injections; it applies to any significant caloric deficit, including post-bariatric-surgery weight loss.

Knowing the difference between ordinary GI discomfort and a gallbladder warning sign is genuinely useful. Ordinary nausea from tirzepatide or semaglutide tends to sit centrally, often behind the sternum or in the upper-middle abdomen, and improves between meals or with small sips of water. Gallbladder pain typically starts in the upper-right quadrant, may radiate toward the right shoulder blade, and often peaks 30–90 minutes after a fatty meal. If you're uncertain which you're experiencing, that's exactly the sort of question our prescribers discuss as part of ongoing aftercare.

When to get medical help without delay

Some symptoms during treatment with weight loss injections warrant prompt assessment, not a wait-and-see approach. Seek urgent medical attention if you experience severe or persistent pain in the upper right or centre of your abdomen, particularly if it spreads to your back or right shoulder. Fever and chills alongside abdominal pain can indicate cholecystitis (inflammation of the gallbladder) or, less commonly, a stone blocking the bile duct, both of which need rapid treatment.

Yellowing of the skin or whites of the eyes (jaundice), dark urine or pale stools alongside any of the above are signs that bile flow may be obstructed and should prompt a same-day call to your GP or, out of hours, NHS 111. Do not wait for your next review appointment.

GLP-1 medicines also carry a separately recognised risk of acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update highlighting pancreatitis as an infrequent but potentially serious effect of this medicine class. The cardinal sign is severe, persistent stomach pain that reaches the back, sometimes with vomiting. Because gallbladder disease and pancreatitis can overlap (a gallstone blocking the pancreatic duct is a common trigger for pancreatitis), it's worth being alert to both. If you experience that kind of pain, call 999 or go to A&E rather than waiting.

The full detail on gallbladder issues and GLP-1 treatment includes a broader look at how these conditions interact and what monitoring your prescriber may recommend.

What if you've already had your gallbladder removed?

This question comes up more than you might expect. Around 70,000 cholecystectomies are performed in the UK each year, so many people starting weight loss treatment are living without a gallbladder. The good news is that absence of the gallbladder does not automatically rule out treatment with tirzepatide or semaglutide.

Without a gallbladder, bile drains continuously from the liver into the small intestine rather than being stored and released in controlled bursts. That changes your digestive patterns (loose stools after fatty meals are common) but it removes the anatomical site where gallstones form. In that sense, some of the gallbladder-specific risk simply doesn't apply. What does still apply is the broader picture: your prescriber needs to know your surgical history, any ongoing digestive symptoms, and whether post-cholecystectomy syndrome (persistent GI symptoms after removal) might complicate the GI side-effect profile of these medicines.

For a thorough look at the evidence, this page covers whether weight loss injections are suitable when you have no gallbladder, including what your prescriber weighs up. And if your surgery is more recent and you're wondering about timing, the guide to starting treatment after gallbladder removal addresses that question directly.

How our prescribers approach gallbladder history in your consultation

When you complete a consultation through nume, the clinical questionnaire asks about your medical history, including any previous gallbladder disease or surgery. This isn't box-ticking. A GPhC-registered prescriber reads your answers personally; your case doesn't pass through an algorithm. If you've had gallstones, cholecystitis or a cholecystectomy, that information shapes the clinical decision about whether treatment is appropriate and, if so, which medicine and starting dose suit your profile.

The consultation is free, and if you order by midday Monday to Friday, your prescriber reviews your case the same day. There is no subscription and no automatic renewal; every repeat order is clinically re-reviewed. You can verify our pharmacy registration on the GPhC register (registration 9012878).

If you'd like to understand the broader side-effect picture for these medicines, our overview of how weight loss injections work covers mechanism and tolerability in more detail. Questions about cost sit on the treatment cost page, where we lay out what is and isn't included in a single price. For anything specific before you start, our clinical team is available, get in touch or go straight to the consultation.

If you're ready to talk through your suitability, including any gallbladder history, speak to our prescribers via a free consultation.